Acetyl-L-carnitine

Also called ALCAR, ALC, acetylcarnitine, acetyl-L-carnitine HCl, acetyl-L-carnitine arginate

By Kymata Labs EditorialMedical review pendingLast reviewed October 11, 2026 · What changed

Kymata Health may earn a commission from the partner product links in the Where to buy section, marked where they appear. Educational reference, not medical advice.

Summary

Acetyl-L-carnitine is a carnitine ester. Pooled trials found fewer depressive symptoms than placebo (12 RCTs, grade B) and small gains in mild cognitive impairment. For nerve pain, a 2015 analysis found moderate pain relief, but a 2019 Cochrane review called diabetic nerve-pain evidence very uncertain.

Top graded outcomes:B evidence grade Depressive symptomsC evidence grade Peripheral nerve pain

Key facts

What it is
Carnitine with an acetyl group; used to move fatty acids into mitochondria[1]
Best-studied outcome
Depressive symptoms (12 RCTs, 791 people; grade B)[1]
Memory evidence
A 2003 pooled analysis in MCI and mild Alzheimer disease found a small advantage over placebo (effect size 0.20)[3]
Evidence caveat
Cochrane (2019): very uncertain benefit for diabetic nerve pain; manufacturer funding in included trials[4]
Evidence base
2 graded human outcomes on this page
Last reviewed
October 11, 2026

How it works

ProposedAcetyl-L-carnitine supplies carnitine for fatty-acid transport into mitochondria and acetyl groups for acetylcholine. Effects on mood and nerves are proposed to involve mitochondrial energy and neurotransmitter support.[1]

What the human research says

Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.

At a glance: strongest evidence per outcome

Evidence at a glance: strongest human evidence per outcome
OutcomeGradeEffectStrongest evidenceRows
MoodGrade BImprovedMeta-analysis of 12 trials · n = 791 · 2018Form tested: Acetyl-L-carnitine1 rowIncludes this form
Nerve painGrade CImprovedMeta-analysis of 4 trials · n = 523 · 2015Form tested: Acetyl-L-carnitine1 rowIncludes this form

Every graded row

Outcome
Grade
Sort

Showing 2 of 2 outcomes. Human trials only.

OutcomeEffectGradeBest evidencePMID
Depressive symptomsImprovedGrade B

Meta-analysis · n = 791 · 2018

Adults (mean age 54) in 12 RCTs

Form: Acetyl-L-carnitine · Dose: Varied across trials · Duration: Varied across trials

Depressive symptoms fell versus placebo or no treatment; effects were similar to antidepressants in head-to-head trials, with fewer side effects.

29076953 (opens PubMed)Source [1]
Peripheral nerve painImprovedGrade C

Meta-analysis · n = 523 · 2015

Adults with peripheral neuropathic pain in 4 RCTs

Form: Acetyl-L-carnitine · Dose: Varied across trials · Duration: Varied across trials

Pain on a visual scale fell moderately versus placebo, more clearly in diabetic neuropathy.

25751285 (opens PubMed)Source [2]

Forms

FormElemental %Absorption (human data)GI toleranceStudied for
Acetyl-L-carnitine HClVariesNot applicable (whole compound or extract; no elemental fraction)The form used in most trials cited here; no head-to-head absorption data versus other salts.Adverse events were similar to placebo in the pooled nerve-pain trials.[2]Mood, memory and nerve-pain trials
Acetyl-L-carnitine arginateVariesNot applicable (whole compound or extract; no elemental fraction)No outcome trials of this salt in the sources cited here.No separate tolerance data in the sources cited here.Sold as a supplement form

Studied doses

Doses studied in human trials ranged from about 1 g/day to 3 g/day, usually for 3 to 12 months in memory and nerve-pain studies.[1][2][3]

These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Interactions

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

None found in our sources.

Who should be careful

Diabetic nerve pain
Cochrane judged the evidence very uncertain and noted that included trials were funded by, or had authors tied to, ALC manufacturers.[4]
Pregnancy and breastfeeding
The trials cited here enrolled non-pregnant adults.[1]

Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

Where to buy Acetyl-L-carnitine

Products from brands we partner with that contain Acetyl-L-carnitine. Listing a product is not a claim that it works; check the amount per serving against the doses studied above, and the label for other ingredients.

  • SupersmartPaid linkAcetyl L-Carnitine Arginate2 capsules: 1,000 mg acetyl-L-carnitine arginate (a different salt from the HCl form used in most trials); 50 servingsShop at Supersmart (opens in new tab)Price and label checked 2026-10-11 on the brand’s site.

    Partner links may earn us a commission. Learn more

    One-time
    $42
    Subscription
    $35.70

    15% off with code SMART026

    Enter code SMART026 at checkout on us.supersmart.com.

    Code SMART026

    Get 15% off with SMART026 (opens in new tab)

    Partner links may earn us a commission. Learn more

    • Supersmart’s own terms and exclusions apply at checkout.
    • 20% applies when 3 or more products ship on auto-delivery to the same address.
    • The code discount and Subscribe & Save are separate offers; we don’t claim they combine.
    • Offer terms from Supersmart’s site and its affiliate program, checked Oct 8, 2026. Offers can change; the brand's checkout is final.

Frequently asked questions

Is acetyl-L-carnitine better than L-carnitine for the brain?

Acetyl-L-carnitine is the form tested in most mood and memory trials; L-carnitine trials focus on exercise and weight.[1]

Does it help depression?

Pooled trials found fewer depressive symptoms than placebo, mostly in older adults. Larger trials are still needed.[1]

Does it help diabetic nerve pain?

One analysis found moderate pain relief, but Cochrane rated the evidence very uncertain.[2][4]

What doses were used?

Most trials used 1–3 g/day.[1][2]

Sources

  1. [1]Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.. Psychosom Med, 2018. meta-analysis PMID 29076953
  2. [2]Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.. PLoS One, 2015. meta-analysis PMID 25751285
  3. [3]Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.. Int Clin Psychopharmacol, 2003. meta-analysis PMID 12598816
  4. [4]Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.. Cochrane Database Syst Rev, 2019. systematic-review PMID 31201734

What changed

  1. October 11, 2026 · Evidence · Adversarial reviewCorrected the effect arrow (↑ improved, ↓ worsened for participants) on: Depressive symptoms; Peripheral nerve pain.Writer: Kymata Labs Editorial · No credentialed reviewer yet
  2. October 11, 2026 · all · new page (encyclopedia expansion, A–L)First draft. Every PMID checked against NCBI E-utilities (title, journal and year taken from the PubMed record) and each evidence row written from its PubMed abstract.Writer: Kymata Labs Editorial · No credentialed reviewer yet

How we write, grade and correct these pages: editorial and evidence policy.

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Supplements and vitamins: every page →Supplement & Nutrient Encyclopedia →Browse all topics →

Evidence-graded supplement stacks →